P3 HEALTH PARTNERS INC (PIII) Stock Overview
NASDAQ:PIII - US7444132044 - Common Stock
PIII Key Statistics, Chart & Performance
The current stock price of PIII is 8.7742 USD. In the past month the price increased by 28.47%. In the past year, price decreased by -61.85%.
PIII Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.64 | 93.58B | ||
| CI | THE CIGNA GROUP | 10.87 | 81.50B | ||
| LH | LABCORP HOLDINGS INC | 18.41 | 23.16B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.4 | 20.52B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 112.76 | 14.78B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 12.14 | 14.54B | ||
| HIMS | HIMS & HERS HEALTH INC | 60.51 | 10.94B | ||
| DVA | DAVITA INC | 14.23 | 9.86B | ||
| GH | GUARDANT HEALTH INC | N/A | 7.50B | ||
| CHE | CHEMED CORP | 20.81 | 6.78B | ||
| RDNT | RADNET INC | 198.36 | 5.49B | ||
| OPCH | OPTION CARE HEALTH INC | 21.55 | 4.72B |
Related stock screener links
About PIII
Company Profile
P3 Health Partners, Inc. is a population health care management company, which engages in the provision of professional support services to doctors and clinicians. The company is headquartered in Chicago, Illinois and currently employs 360 full-time employees. The company went IPO on 2021-02-10. The firm supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. The company has a network of more than 3,100 affiliated primary care providers across the country. Its local teams of healthcare professionals manage the care of thousands of patients in 27 counties across five states.
Company Info
P3 HEALTH PARTNERS INC
2045 W Grand Ave Ste B, Pmb # 82152
Chicago ILLINOIS US
Employees: 360
Phone: 13128228897
P3 HEALTH PARTNERS INC / PIII FAQ
What is the stock price of P3 HEALTH PARTNERS INC today?
The current stock price of PIII is 8.7742 USD. The price increased by 0.12% in the last trading session.
What is the ticker symbol for P3 HEALTH PARTNERS INC stock?
The exchange symbol of P3 HEALTH PARTNERS INC is PIII and it is listed on the Nasdaq exchange.
On which exchange is PIII stock listed?
PIII stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for P3 HEALTH PARTNERS INC stock?
10 analysts have analysed PIII and the average price target is 13.94 USD. This implies a price increase of 58.87% is expected in the next year compared to the current price of 8.7742. Check the P3 HEALTH PARTNERS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is P3 HEALTH PARTNERS INC worth?
P3 HEALTH PARTNERS INC (PIII) has a market capitalization of 63.09M USD. This makes PIII a Micro Cap stock.
How many employees does P3 HEALTH PARTNERS INC have?
P3 HEALTH PARTNERS INC (PIII) currently has 360 employees.
What are the support and resistance levels for P3 HEALTH PARTNERS INC (PIII) stock?
P3 HEALTH PARTNERS INC (PIII) has a resistance level at 8.78. Check the full technical report for a detailed analysis of PIII support and resistance levels.
Is P3 HEALTH PARTNERS INC (PIII) expected to grow?
The Revenue of P3 HEALTH PARTNERS INC (PIII) is expected to decline by -5.14% in the next year. Check the estimates tab for more information on the PIII EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy P3 HEALTH PARTNERS INC (PIII) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PIII, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PIII, evaluating the profitability, health, valuation and growth aspects
- P3 HEALTH PARTNERS INC (PIII) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- P3 HEALTH PARTNERS INC (PIII) Sales and EPS estimates to see what analysts future expectations are.
- P3 HEALTH PARTNERS INC (PIII) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- P3 HEALTH PARTNERS INC (PIII) Insider and Institutional Ownership to learn about the owners and their transactions.
- P3 HEALTH PARTNERS INC (PIII) Stock Chart to make your own analysis
- P3 HEALTH PARTNERS INC (PIII) Latest news and press-releases to stay up to date.
Does P3 HEALTH PARTNERS INC (PIII) stock pay dividends?
PIII does not pay a dividend.
When does P3 HEALTH PARTNERS INC (PIII) report earnings?
P3 HEALTH PARTNERS INC (PIII) will report earnings on 2025-11-10.
What is the Price/Earnings (PE) ratio of P3 HEALTH PARTNERS INC (PIII)?
P3 HEALTH PARTNERS INC (PIII) does not have a PE ratio as the earnings reported over the last twelve months were negative (-46.51).
What is the Short Interest ratio of P3 HEALTH PARTNERS INC (PIII) stock?
The outstanding short interest for P3 HEALTH PARTNERS INC (PIII) is 2.02% of its float. Check the ownership tab for more information on the PIII short interest.
PIII Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to PIII. When comparing the yearly performance of all stocks, PIII is a bad performer in the overall market: 87.33% of all stocks are doing better.
PIII Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to PIII. PIII has a bad profitability rating. Also its financial health evaluation is rather negative.
PIII Financial Highlights
Over the last trailing twelve months PIII reported a non-GAAP Earnings per Share(EPS) of -46.51. The EPS decreased by -57.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -19.95% | ||
| ROE | -328.33% | ||
| Debt/Equity | 2.3 |
PIII Forecast & Estimates
10 analysts have analysed PIII and the average price target is 13.94 USD. This implies a price increase of 58.87% is expected in the next year compared to the current price of 8.7742.
For the next year, analysts expect an EPS growth of 62.59% and a revenue growth -5.14% for PIII